Reynold A. Panettieri Jr., M.D., Expert, GERM of Exchange Traded Managers Group, LLC as well as Vice Chancellor, Translational Medicine and Science, and Director, Rutgers Institute for Translational Medicine and Science. Dr. Panettieri, in addition to being the named expert to the ETFMG Treatments, Testing and Advancements ETF (NYSEARCA:GERM), is Professor of Medicine, Vice Chancellor for Translational Medicine and Science at Rutgers University and the Director of the Institute for Translational Medicine and Science. Previously, he was the Robert L. Mayock and David A. Cooper Professor of Medicine in the Pulmonary, Allergy and Critical Care Division of the Department of Medicine and served as Deputy Director of the Center of Excellence in Environmental Toxicology at the University of Pennsylvania Perelman School of Medicine where he remains professor emeritus. Dr. Panettieri is also the recipient of numerous honors and awards, including the Robert E. Cooke Memorial Lectureship at the American Academy of Allergy, Asthma and Immunology Annual Meeting, the Joseph R. Rodarte Award for Scientific Distinction and the Recognition Award for Scientific Accomplishments from the American Thoracic Society, or ATS. He is also an active member of national professional and scientific societies including the American College of Chest Physicians and ATS; in 2013, he was elected Chair of the Respiratory Structure and Function Assembly of ATS. Dr. Panettieri served as Chair of the NIH Lung Cellular, Molecular and Immunobiology Study Section; is a member of the NIH Distinguished Editorial Panel; and is a member of the American Society for Clinical Investigation and Association of American Physicians. Dr. Panettieri is principal investigator on several NIH-sponsored grants and industry-sponsored clinical studies, is director of a program project grant examining novel approaches in modulating G protein-coupled receptor function and is the principal investigator of the CTSA Hub entitled “New Jersey Alliance for Clinical and Translational Science.” He is the author of over 475 peer-reviewed publications. Dr. Panettieri manages the comprehensive clinical care of patients with asthma and is engaged in clinical investigations focused on the management of asthma and COPD.
Using an Exchange-Traded Fund to Invest in Infectious Disease
September 04, 2020